|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.959
|
|
|
|
metanephric glomerular visceral epithelial cell development
|
GO:0072249 |
2 |
0.900
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.702
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.608
|
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.526
|
|
|
|
regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010640 |
9 |
0.451
|
|
|
|
metanephric glomerular epithelial cell differentiation
|
GO:0072312 |
2 |
0.448
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.442
|
Human |
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.393
|
|
|
|
metanephric glomerular visceral epithelial cell differentiation
|
GO:0072248 |
2 |
0.393
|
|
|
|
metanephric glomerular epithelial cell development
|
GO:0072313 |
2 |
0.377
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.376
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.372
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.361
|
|
|
|
positive regulation of camp dependent protein kinase activity
|
GO:2000481 |
3 |
0.349
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.334
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.333
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.326
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.302
|
|
|
|
positive regulation of natural killer cell chemotaxis
|
GO:2000503 |
1 |
0.273
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.267
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.261
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.221
|
|
|
|
negative regulation of hypersensitivity
|
GO:0002884 |
3 |
0.213
|
|
|
|
detection of oxidative stress
|
GO:0070994 |
1 |
0.206
|
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.203
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.199
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.188
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.181
|
|
|
|
negative regulation of metanephros development
|
GO:0072217 |
6 |
0.171
|
|
|
|
cell migration involved in metanephros development
|
GO:0035788 |
2 |
0.171
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.168
|
|
|
|
regulation of epithelial cell differentiation involved in kidney development
|
GO:2000696 |
10 |
0.168
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.166
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.165
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.159
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.157
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.156
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.150
|
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.150
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.148
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.146
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.144
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.140
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.138
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.137
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.137
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.135
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.129
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.127
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.126
|
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.124
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.123
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.123
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.122
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.122
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.122
|
Human |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.121
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.120
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.118
|
|
|
|
cerebellar granular layer formation
|
GO:0021684 |
9 |
0.117
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.117
|
Mouse |
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.117
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.116
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.116
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.115
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.114
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.108
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.108
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.107
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.107
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.106
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.105
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.101
|
|
|
|
renal protein absorption
|
GO:0097017 |
1 |
0.099
|
|
|
|
cerebellar granule cell differentiation
|
GO:0021707 |
9 |
0.098
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.098
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.096
|
|
|
|
renal filtration cell differentiation
|
GO:0061318 |
10 |
0.094
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.092
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.092
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.089
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
7 |
0.088
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.087
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.087
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.086
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.083
|
|
|
|
negative regulation of kidney development
|
GO:0090185 |
15 |
0.083
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.082
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.082
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.082
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.082
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.082
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.081
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.080
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.080
|
|
|
|
negative regulation of metanephric mesenchymal cell migration
|
GO:2000590 |
1 |
0.079
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.079
|
|
|
|
g protein coupled purinergic nucleotide receptor signaling pathway
|
GO:0035589 |
1 |
0.078
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.077
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.076
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.076
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.076
|
|
|
|
cerebellar granular layer development
|
GO:0021681 |
13 |
0.074
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.073
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.073
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.073
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.073
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.072
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.072
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.072
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.071
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.070
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.070
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.070
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.070
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.070
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.069
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.069
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.069
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.068
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.068
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.067
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
6 |
0.067
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.067
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.067
|
|
|
|
regulation of glucose import
|
GO:0046324 |
26 |
0.066
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.066
|
|
|
|
positive regulation of glomerulus development
|
GO:0090193 |
5 |
0.066
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.065
|
|
|
|
positive regulation of type iii hypersensitivity
|
GO:0001805 |
3 |
0.065
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.064
|
|
|
|
negative regulation of inflammatory response to antigenic stimulus
|
GO:0002862 |
10 |
0.064
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.064
|
|
|
|
regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000583 |
2 |
0.063
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.063
|
|
|
|
positive regulation of renal albumin absorption
|
GO:2000534 |
1 |
0.063
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.063
|
|
|
|
neutrophil activation involved in immune response
|
GO:0002283 |
8 |
0.063
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.062
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.062
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.061
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.061
|
Mouse |
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.061
|
|
|
|
regulation of renal albumin absorption
|
GO:2000532 |
1 |
0.061
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.061
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.060
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.060
|
|
|
|
glomerular epithelial cell development
|
GO:0072310 |
6 |
0.060
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.059
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.059
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.059
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.058
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.058
|
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.058
|
|
|
|
regulation of natural killer cell chemotaxis
|
GO:2000501 |
1 |
0.057
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.057
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.057
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.057
|
|
|
|
macrophage migration inhibitory factor signaling pathway
|
GO:0035691 |
2 |
0.057
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.056
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.056
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.055
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.054
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.054
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.054
|
|
|
|
positive regulation of metanephric glomerular visceral epithelial cell development
|
GO:2000478 |
1 |
0.054
|
|
|
|
regulation of type iii hypersensitivity
|
GO:0001803 |
3 |
0.054
|
|
|
|
regulation of glucose transport
|
GO:0010827 |
32 |
0.053
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.053
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.053
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.052
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.052
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.051
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.051
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.051
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.051
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.049
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.049
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.049
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.049
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.048
|
|
|
|
cellular response to hydroperoxide
|
GO:0071447 |
4 |
0.048
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.048
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.047
|
|
|
|
regulation of type iia hypersensitivity
|
GO:0001796 |
4 |
0.047
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.047
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.047
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.047
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.047
|
|
|
|
positive regulation of glucose transport
|
GO:0010828 |
16 |
0.046
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.046
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.045
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.045
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.045
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.045
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.045
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.044
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.044
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.044
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.044
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.044
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.043
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.043
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.043
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.043
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.042
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.042
|
|
|
|
adiponectin secretion
|
GO:0070162 |
2 |
0.042
|
|
|
|
negative regulation of carbohydrate metabolic process
|
GO:0045912 |
19 |
0.042
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.041
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.041
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.041
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.041
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.041
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.041
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.041
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.041
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.041
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.040
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.040
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.040
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.040
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.040
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.039
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.039
|
|
|
|
fatty acid beta oxidation
|
GO:0006635 |
16 |
0.039
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.039
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.039
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.039
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.039
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.038
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.038
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.038
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.038
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.038
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.038
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.037
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.037
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.037
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
18 |
0.037
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.037
|
|
|
|
complement activation classical pathway
|
GO:0006958 |
2 |
0.037
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
42 |
0.037
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.036
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.036
|
|
|
|
glomerular visceral epithelial cell development
|
GO:0072015 |
6 |
0.036
|
|
|
|
regulation of metanephric glomerular visceral epithelial cell development
|
GO:2000477 |
1 |
0.036
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.036
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.036
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.036
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.035
|
|
|
|
positive regulation of glucose import
|
GO:0046326 |
14 |
0.035
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.035
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.035
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.034
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.034
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.034
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.034
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.034
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.033
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.033
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.033
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.033
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.033
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.033
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.033
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.032
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.032
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.032
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.032
|
|
|
|
positive regulation of metanephros development
|
GO:0072216 |
9 |
0.032
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.032
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.032
|
|
|
|
negative regulation of type i hypersensitivity
|
GO:0001811 |
1 |
0.031
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.031
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.031
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.031
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.031
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.031
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.031
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.030
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.030
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.030
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.030
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.030
|
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
24 |
0.030
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.030
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.030
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
23 |
0.030
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.029
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.029
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.029
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.029
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.029
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.029
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.029
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.029
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.029
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.029
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.029
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.029
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.029
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.028
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.028
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.028
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.028
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.028
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.028
|
Mouse |
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.028
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.028
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.028
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.028
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.027
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.027
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.027
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.027
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.027
|
Mouse |
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.027
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.027
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.027
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.027
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.027
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.027
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.027
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.027
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.027
|
|
|
|
humoral immune response mediated by circulating immunoglobulin
|
GO:0002455 |
14 |
0.027
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.026
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.026
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.026
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.026
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.026
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.026
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.026
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
20 |
0.026
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.026
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.025
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.025
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.025
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.025
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.025
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.025
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.025
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.025
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.025
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.025
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.025
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.025
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.025
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.025
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.025
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.025
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.024
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.024
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.024
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.024
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
positive regulation of immunoglobulin production
|
GO:0002639 |
28 |
0.024
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.024
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.023
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.023
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.023
|
|
|
|
glomerular epithelial cell differentiation
|
GO:0072311 |
10 |
0.023
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.023
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.023
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.023
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.023
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.023
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.023
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.023
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.023
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.023
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.023
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.022
|
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class i
|
GO:0042590 |
6 |
0.022
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.022
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.022
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.022
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
hypersensitivity
|
GO:0002524 |
10 |
0.022
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.022
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.022
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.022
|
|
|
|
negative regulation of macrophage differentiation
|
GO:0045650 |
4 |
0.022
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.022
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.021
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.021
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.021
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.021
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.021
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.021
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.021
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.021
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.021
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.021
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.021
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.021
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.021
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.021
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.020
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.020
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.020
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.020
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.020
|
Mouse |
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.020
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.020
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.020
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.019
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.019
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.019
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.019
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.019
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.019
|
|
|
|
regulation of adiponectin secretion
|
GO:0070163 |
2 |
0.019
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.019
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.019
|
|
|
|
arp2 3 complex mediated actin nucleation
|
GO:0034314 |
3 |
0.019
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.019
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.018
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.018
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.018
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.018
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.018
|
Mouse |
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.018
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.018
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.018
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.018
|
|
|
|
regulation of immunoglobulin production in mucosal tissue
|
GO:2000557 |
1 |
0.018
|
|
|
|
regulation of t cell mediated immunity
|
GO:0002709 |
34 |
0.018
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.018
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.018
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.018
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.018
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.017
|
|
|
|
positive regulation of syncytium formation by plasma membrane fusion
|
GO:0060143 |
17 |
0.017
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.017
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.017
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.017
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.017
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.017
|
|
|
|
fc epsilon receptor signaling pathway
|
GO:0038095 |
3 |
0.017
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.017
|
|
|
|
cerebellar granular layer morphogenesis
|
GO:0021683 |
10 |
0.017
|
|
|
|
heterophilic cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0007157 |
20 |
0.017
|
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
29 |
0.017
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.017
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.017
|
|
|
|
positive regulation of granulocyte macrophage colony stimulating factor biosynthetic process
|
GO:0045425 |
2 |
0.017
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.017
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.017
|
|
|
|
cell cell junction maintenance
|
GO:0045217 |
3 |
0.017
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.017
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.017
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.017
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.016
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.016
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.016
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.016
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.016
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.016
|
|
|
|
renal albumin absorption
|
GO:0097018 |
1 |
0.016
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.016
|
|
|
|
regulation of type 2 immune response
|
GO:0002828 |
18 |
0.016
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.016
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.016
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.016
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.016
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.016
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.016
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.016
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.016
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.016
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.015
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.015
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.015
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.015
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.015
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.015
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.015
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.015
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.015
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.015
|
|
|
|
positive regulation of muscle adaptation
|
GO:0014744 |
2 |
0.015
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.015
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.015
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
|
regulation of macrophage differentiation
|
GO:0045649 |
9 |
0.015
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.015
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.015
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.014
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.014
|
|
